Form 4: Albemarle Director James J. OBrien Reports Stock Award and Dividend Accrual
SEC Form 4 Filing
Director James J. OBrien reports acquisition of Albemarle Corp. stock through a director stock compensation plan and dividend accrual.
Summary
- On July 1, 2024, James J. OBrien, a director of Albemarle Corporation, acquired 1,750 shares of common stock as an annual award under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors.
- These shares will vest on July 1, 2025.
- Additionally, Mr. OBrien acquired 10 shares representing dividends accrued on shares underlying an award granted on July 3, 2023, which vested on July 1, 2024.
- The issuer elected to settle these dividends in shares of common stock issued under the 2023 Directors Plan.
- Following these transactions, Mr. OBrien beneficially owns 5,323 shares of Albemarle Corporation common stock directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions related to director compensation. There are no explicit positive or negative indicators, but the director's continued stock ownership suggests confidence.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
- The dividend accrual and subsequent share issuance demonstrate the company's commitment to rewarding its directors.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of shares in July 2025 suggests a continued relationship between the director and the company.
Industry Context
This filing is a routine disclosure related to director compensation, which is a common practice in publicly traded companies. It reflects standard corporate governance procedures.
Comparison to Industry Standards
- Director compensation packages, including stock awards and dividend accruals, are common across publicly traded companies, particularly in the chemical and specialty materials sectors.
- Companies like Dow, DuPont, and BASF also utilize stock-based compensation to align director interests with shareholder value.
- The specific terms of Albemarle's 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors would need to be compared to similar plans at peer companies to assess its competitiveness.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 07/03/2023 | Date of award granted that vested in full on July 1, 2024. |
| 07/01/2024 | Date of transaction: Acquisition of 1,750 shares as annual director stock compensation and 10 shares representing accrued dividends. |
| 07/01/2025 | Vesting date for the 1,750 shares acquired as annual director stock compensation. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.